Items
Linked e-resources
Details
Table of Contents
Introduction : the psychedelic renaissance continues / Michael Winkelman and Ben Sessa
Psychedelics and psychiatry : a new treatment model for the 21st century / Charlie Grob and Gary Bravo
Therapeutic applications of 3,4-methyldioxmethamphetamine (MDMA) / Ben Sessa
Psilocybin therapy for major depressive disorder / James Rucker
Ketamine therapy for treatment resistant depression / L. Alison McInnes and Marc Ettensohn
Evidence for the therapeutic effects of ayahuasca / Draulio Barros de Araujo
Psilocybin for the treatment of substance use disorders / Ishani Rao and Greg Lydall
Potential applications of cannabis and cannabinoids in the treatment of substance use disorder and in harm reduction / Jose Carlos Bouso, Rafael G. dos Santos and Jaime Hallak
Psychedelic therapy as a complementary treatment approach for alcohol use disorders / Peter Eischens and William Leigh Atherton
Effects of psychedelics on inflammation and immunity / Attila Szabo
The protective role of dimethyltryptamine against ischemia-reperfusion injury / Ede Frecska, Attila Kovacs, and Attila Szabo
Psychedelic treatment of disruptive personality patterns / Petr Winkler and Rita Kocárová
Guidelines in applying psychedelic therapies / Friederike Meckel
Training psychedelic therapists / Janis Phelps
Community-based full-spectrum harm reduction approaches when caring for psychoactive and psychedelic related problems in a transformational festival / Maria Carmo Carvalho, Cristiana V. Pires, Ana Luísa Costa, Daniel Martins, Helena Valente, Ines Macedo, Paula Frango and Raquel Lira
Microdosing psychedelics / James Fadiman and Sophia Korb
Bringing psychedelics and entactogens into mainstream pharmaceuticals : a focus on MDMA / Anne C. Wagner, Michael C. Mithoefer, and Rick Doblin.
Psychedelics and psychiatry : a new treatment model for the 21st century / Charlie Grob and Gary Bravo
Therapeutic applications of 3,4-methyldioxmethamphetamine (MDMA) / Ben Sessa
Psilocybin therapy for major depressive disorder / James Rucker
Ketamine therapy for treatment resistant depression / L. Alison McInnes and Marc Ettensohn
Evidence for the therapeutic effects of ayahuasca / Draulio Barros de Araujo
Psilocybin for the treatment of substance use disorders / Ishani Rao and Greg Lydall
Potential applications of cannabis and cannabinoids in the treatment of substance use disorder and in harm reduction / Jose Carlos Bouso, Rafael G. dos Santos and Jaime Hallak
Psychedelic therapy as a complementary treatment approach for alcohol use disorders / Peter Eischens and William Leigh Atherton
Effects of psychedelics on inflammation and immunity / Attila Szabo
The protective role of dimethyltryptamine against ischemia-reperfusion injury / Ede Frecska, Attila Kovacs, and Attila Szabo
Psychedelic treatment of disruptive personality patterns / Petr Winkler and Rita Kocárová
Guidelines in applying psychedelic therapies / Friederike Meckel
Training psychedelic therapists / Janis Phelps
Community-based full-spectrum harm reduction approaches when caring for psychoactive and psychedelic related problems in a transformational festival / Maria Carmo Carvalho, Cristiana V. Pires, Ana Luísa Costa, Daniel Martins, Helena Valente, Ines Macedo, Paula Frango and Raquel Lira
Microdosing psychedelics / James Fadiman and Sophia Korb
Bringing psychedelics and entactogens into mainstream pharmaceuticals : a focus on MDMA / Anne C. Wagner, Michael C. Mithoefer, and Rick Doblin.